Form 4: USANA Legal Officer Foukas Boosts Direct Stock Holdings

USANA Health Sciences Chief Legal Officer Joshua Foukas increased his direct common stock ownership through RSU vesting and tax-related dispositions.

Summary

• Joshua Foukas, Chief Legal Officer of USANA Health Sciences Inc. (USNA), reported multiple transactions involving common stock and Restricted Stock Units (RSUs).
• On February 6, 2026, Foukas acquired 3,111 shares of common stock upon RSU vesting and disposed of 1,483 shares for tax withholding at $21.34 per share, resulting in 1,628 directly owned common shares.
• On February 7, 2026, he acquired 1,571 shares of common stock from RSU vesting and disposed of 749 shares for tax withholding at $21.34 per share, increasing his direct common stock ownership to 2,450 shares.
• On February 8, 2026, Foukas acquired 3,597 shares of common stock from RSU vesting and disposed of 1,586 shares for tax withholding at $21.34 per share, bringing his direct common stock ownership to 4,461 shares.
• The RSUs converted represent contingent rights to receive one share of USNA common stock, with vesting dates on the anniversaries of February 6, 2023, February 7, 2022, and February 8, 2024, respectively.
• Following these transactions, Foukas's direct beneficial ownership of Restricted Stock Units decreased from 41,776 to 36,608.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider filing reflecting the vesting of executive compensation. The net increase in direct common stock ownership is a minor positive, indicating continued alignment.

Positives

• Increased direct common stock ownership by a key executive, Joshua Foukas, from 1,628 shares on February 6, 2026, to 4,461 shares on February 8, 2026, indicating continued alignment with shareholder interests.
• The transactions are primarily due to the vesting of Restricted Stock Units, a common form of executive compensation, suggesting a planned and regular equity award process.

Negatives

• A portion of the vested common stock was immediately disposed of (1,483 shares, 749 shares, and 1,586 shares) to cover tax obligations, which is a standard practice but reduces the net increase in direct ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to equity compensation vesting, are common across industries. While these transactions provide insight into executive ownership, they are generally routine and do not typically signal significant strategic shifts or financial performance changes unless they involve large, unprompted open-market purchases or sales.

Comparison to Industry Standards

• This type of transaction, involving the vesting of restricted stock units and subsequent sale of shares to cover tax liabilities, is a standard practice for executive compensation across publicly traded companies.
• It aligns with typical equity incentive plans designed to retain and incentivize key personnel.
• No specific comparable companies or projects are mentioned in the filing to allow for a direct comparison of results.

Related Party Transactions

• The reported transactions involve the Chief Legal Officer of USANA Health Sciences Inc. acquiring common stock through the vesting of Restricted Stock Units and disposing of shares for tax withholding, which are considered related party transactions under SEC rules.

Stakeholder Impact

• Shareholders: The increase in direct common stock ownership by a key executive may be viewed positively as it aligns management's interests with shareholders.
• Employees: The vesting of RSUs demonstrates the company's ongoing equity compensation programs for executives.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation. While the Chief Legal Officer increased his direct common stock holdings, a portion was sold for tax purposes. These transactions are expected and do not provide new fundamental information to warrant a change in investment recommendation. Investors should continue to hold based on broader company fundamentals and market conditions, not solely on this routine insider filing.

Keywords

USANA Health Sciences, USNA, Joshua Foukas, Chief Legal Officer, SEC Form 4, Insider Trading, Restricted Stock Units, RSU vesting, Common Stock, Equity Compensation, Stock Ownership